A blood screening is a therapeutic procedure which allows blood to be analysed for a particular illness or condition. In this process, blood is mostly tried for HIV1, HIV2, HBV, HCV, jungle fever, syphilis, and different irresistible ailments. It is mostly done to reduce the chances of transfusion-transmitted contaminations (TTIs).
Market Overview and Trends
The growth of the blood screening market is due to rise in the screening of donor and technological advancement in this sector. Demand for blood screening tests has been on the rise in recent years thanks to the surge in donation, boosted awareness about transfusion-transmitted diseases, and technological advancements among others. Moreover, governments across the nations are striving to mandate testing of all the donated blood for a number of viruses.
Factors Influencing the Market Growth:
• The ever increasing demand for donated blood and the donors.
• The increased number of blood donation camps.
• Higher awareness among users regarding safety and knowledge of donated blood.
• Economic price and acceptance of NAT for blood screening
Factors Restraining the Market Growth:
• Lack of proper regulations in developing countries for the use of NAT
• Lack of finance required for capital investments and high maintenance cost of NAT, especially in emerging markets
• Evolution of substitute technologies
Market Segmentation 2019-2029:
The blood screening market is segmented on the technologies, product & service types, geography.
Technologies Covered:
• Nucleic Acid Amplification Test (NAT)
• Transcription-Mediated Amplification (TMA)
• Real-Time Polymerase Chain Reaction (PCR)
• Enzyme-Linked Immunosorbent Assay (ELISA)
• ELISA Market, By Platform
• ELISA Market, By Generation
• Rapid Tests
• Next-Generation Sequencing (NGS)
• Western Blotting
Product & Service Types Covered:
• Reagent and Kits Market, 2019-2029
• NAT Reagents & Kits Market, 2019-2029
• ELISA Reagents & Kits Market, 2019-2029
• Enzymes and Polymerases Market, 2019-2029
• Standards And Controls Market, 2019-2029
• Probes And Primers Market, 2019-2029
• Buffers, Nucleotides, And Solutions Market, 2019-2029
• Immunosorbents Market, 2019-2029
• Controls Market, 2019-2029
• Instruments Market, 2019-2029
• Rental Purchase Market, 2019-2029
• Outright Purchase Market, 2019-2029
• Software and Services Market, 2019-2029
Geographic Breakdown
Focused regional forecasts and analysis explore the future opportunities:
• North America Market, 2019-2029
• Europe Market, 2019-2029
• Asia-Pacific Market, 2019-2029
• LAMEA Market, 2019-2029
Competitive Analysis:
• Research and development is the primary strategy adopted by the key players in the Blood Screening market.
• These companies have developed various strategies and developments such as product launch, partnerships, mergers & acquisitions, joint venture, and collaborations.
Major Market Players:
Grifols, F. Hoffmann-La Roche, Abbott Laboratories, Biomérieux, Bio-Rad Laboratories, Inc., Siemens Healthineers (A Subsidiary Of Siemens AG), Ortho Clinical Diagnostics, Inc., Thermo Fisher Scientific, Inc., Beckman Coulter (A Subsidiary Of Danaher Corporation), Becton, Dickinson And Company
Key questions answered by this report:
• What is the current size of the total global blood Screening market?
• How much will this market be worth from 2018 to 2029?
• How is the blood Screening market evolving?
• What is driving and restraining the blood Screening market?
• What are the market shares of each segment of the overall blood Screening market currently and how will these change to 2029?
• What are the main submarkets and how much revenue will each blood Screening market submarket account for over the next 10 years to 2029 and why?
• How will the market shares for each blood Screening market submarket develop from 2018 to 2029?
• Who are the leading players and what are their prospects over the forecast period?
• How will the industry evolve to 2029?
• What are the largest national markets for blood Screening market? What is the current status and how will it develop over the next ten years? What are their forecasts for 2019-2029?
• Who are the most prominent companies, and what are their activities and outlooks?
• What are the main trends that will affect the blood Screening market between 2018 and 2029?
Visiongain’s study is intended for anyone requiring commercial analyses for the blood Screening market. You find data, trends and predictions.
Buy our report today Blood Screening Market 2019-2029: By Technology (NAT, ELISA, CLIA, NGS, Western Blotting) & By Product (Reagents, Instruments) Segments.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1 Report Overview
1.1 Global Blood Screening Market
1.2 Global Blood Screening Market Overview
1.3 Global Blood Screening Market Segmentation
1.4 Market Drivers
1.5 Why You Should Read This Report
1.6 How This Report Delivers
1.7 Key Questions Answered by This Analytical Report Include:
1.8 Methodology
1.8.1 Secondary Research
1.8.2 Market Evaluation & Forecasting Methodology
1.9 Frequently Asked Questions (FAQ)
1.10 Associated Visiongain Reports
1.11 About Visiongain
2 Introduction to the Blood Screening Market
2.1 Nucleic Acid Amplification Test (NAT)
2.1.1 Transcription-Mediated Amplification (TMA)
2.1.2 Real-Time Polymerase Chain Reaction (PCR)
2.2 Enzyme-Linked Immunosorbent Assay (ELISA)
2.2.1 ELISA Market, By Platform
2.2.2 ELISA Market, By Generation
2.3 Rapid Tests
2.4 Next-Generation Sequencing (NGS)
2.5 Western Blotting
3 Global Blood Screening Market Analysis
3.1 PEST Analysis of the Blood Screening Market
3.2 Expert Opinion
3.2.1 Primary Correspondents
3.3 Blood Screening Market Outlook
3.4 Drivers & Restraints
3.5 Dominant Region/Country
3.6 Blood Screening Overall Operating Scenario
3.7 Overall Growth Rate, Globally
3.8 SWOT Analysis of the Blood Screening Market
3.8.1 Strengths
3.8.2 Weaknesses
3.8.3 Opportunities
3.8.4 Threats
4 Blood Screening: Global Market
4.1 Blood Screening Market Introduction
4.2 Global Blood Screening Reagent and Kits Market 2019-2029
4.2.1 Global Blood Screening NAT Reagents & Kits Market 2019-2029
4.2.2 Global Blood Screening ELISA Reagents & Kits Market 2019-2029
4.3 Global Blood Screening Enzymes and Polymerases Market 2019-2029
4.4 Global Blood Screening Standards And Controls Market 2019-2029
4.5 Global Blood Screening Probes And Primers Market 2019-2029
4.6 Global Blood Screening Buffers, Nucleotides, And Solutions Market 2019-2029
4.7 Global Blood Screening Immunosorbents Market 2019-2029
4.8 Global Blood Screening Controls Market 2019-2029
4.9 Global Blood Screening Instruments Market 2019-2029
4.9.1 Global Blood Screening Rental Purchase Market 2019-2029
4.9.2 Global Blood Screening Outright Purchase Market 2019-2029
4.9.3 Global Blood Screening Software and Services Market 2019-2029
5 Leading Regions in Blood Screening Market 2019-2029
5.1 Regional Overview
5.1.1 North America
5.1.2 Europe
5.1.3 Asia-Pacific
5.1.4 Middle East & Africa
5.1.5 Rest of the World
5.1.6 Leading Countries/ Regions by Blood Screening Market
5.2 Canada Blood Screening Market 2019-2029
5.2.1 Canada Blood Screening Submarket, By Type Forecast 2019-2029
5.2.2 Canada Blood Screening Submarket, By Products and Services Forecast 2019-2029
5.2.3 Canada Blood Screening Market Analysis
5.3 U.S. Blood Screening Market 2019-2029
5.3.1 U.S. Blood Screening Submarket, By Type Forecast 2019-2029
5.3.2 U.S. Blood Screening Submarket, By Products and Services Forecast 2019-2029
5.3.3 U.S. Blood Screening Market Analysis
5.4 Germany Blood Screening Market 2019-2029
5.4.1 Germany Blood Screening Submarket, By Type Forecast 2019-2029
5.4.2 Germany Blood Screening Submarket, By Products and Services Forecast 2019-2029
5.4.3 Germany Blood Screening Market Analysis
5.5 France Blood Screening Market 2019-2029
5.5.1 France Blood Screening Submarket, By Type Forecast 2019-2029
5.5.2 France Blood Screening Submarket, By Products and Services Forecast 2019-2029
5.5.3 France Blood Screening Market Analysis
5.6 U.K. Blood Screening Market 2019-2029
5.6.1 U.K. Blood Screening Submarket, By Type Forecast 2019-2029
5.6.2 U.K. Blood Screening Submarket, By Products and Services Forecast 2019-2029
5.6.3 U.K. Blood Screening Market Analysis
5.7 Italy Blood Screening Market 2019-2029
5.7.1 Italy Blood Screening Submarket, By Type Forecast 2019-2029
5.7.2 Italy Blood Screening Submarket, By Products and Services Forecast 2019-2029
5.7.3 Italy Blood Screening Market Analysis
5.8 Spain Blood Screening Market 2019-2029
5.8.1 Spain Blood Screening Submarket, By Type Forecast 2019-2029
5.8.2 Spain Blood Screening Submarket, By Products and Services Forecast 2019-2029
5.8.3 Spain Blood Screening Market Analysis
5.9 China Blood Screening Market 2019-2029
5.9.1 China Blood Screening Submarket, By Type Forecast 2019-2029
5.9.2 China Blood Screening Submarket, By Products and Services Forecast 2019-2029
5.9.3 China Blood Screening Market Analysis
5.10 Australia Blood Screening Market 2019-2029
5.10.1 Australia Blood Screening Submarket, By Type Forecast 2019-2029
5.10.2 Australia Blood Screening Submarket, By Products and Services Forecast 2019-2029
5.10.3 Australia Blood Screening Market Analysis
5.11 India Blood Screening Market 2019-2029
5.11.1 India Blood Screening Submarket, By Type Forecast 2019-2029
5.11.2 India Blood Screening Submarket, By Products and Services Forecast 2019-2029
5.11.3 India Blood Screening Market Analysis
5.12 Indonesia Blood Screening Market 2019-2029
5.12.1 Indonesia Blood Screening Submarket, By Type Forecast 2019-2029
5.12.2 Indonesia Blood Screening Submarket, By Products and Services Forecast 2019-2029
5.13 India Blood Screening Market 2019-2029
5.13.1 India Blood Screening Submarket, By Type Forecast 2019-2029
5.13.2 India Blood Screening Submarket, By Products and Services Forecast 2019-2029
5.13.3 India Blood Screening Market Analysis
5.14 South Korea Blood Screening Market 2019-2029
5.14.1 5.13.1 South Korea Blood Screening Submarket, By Type Forecast 2019-2029
5.14.2 South Korea Blood Screening Submarket, By Products and Services Forecast 2019-2029
5.14.3 South Korea Blood Screening Market Analysis
5.15 Rest of Asia Blood Screening Market 2019-2029
5.15.1 Rest of Asia Blood Screening Submarket, By Type Forecast 2019-2029
5.15.2 Rest of Asia Blood Screening Submarket, By Products and Services Forecast 2019-2029
5.15.3 Rest of Asia Blood Screening Market Analysis
5.16 Middle East Blood Screening Market 2019-2029
5.16.1 Middle East Blood Screening Submarket, By Type Forecast 2019-2029
5.16.2 Middle East Blood Screening Submarket, By Products and Services Forecast 2019-2029
5.16.3 Middle East Blood Screening Market Analysis
5.17 Africa Blood Screening Market 2019-2029
5.17.1 Africa Blood Screening Submarket, By Type Forecast 2019-2029
5.17.2 Africa Blood Screening Submarket, By Products and Services Forecast 2019-2029
5.17.3 Africa Blood Screening Market Analysis
5.18 Rest of the World Blood Screening Market 2019-2029
5.18.1 Rest of the World Blood Screening Submarket, By Type Forecast 2019-2029
5.18.2 Rest of the World Blood Screening Submarket, By Products and Services Forecast 2019-2029
5.18.3 Rest of the World Blood Screening Market Analysis
6 7. Leading Companies in the Blood Screening Market
6.1 Grifols
6.1.1 Company Overview
6.1.2 Product And Services Overview
6.1.3 Financials Overview
6.1.4 Key Developments
6.1.5 SWOT Analysis
6.2 F. Hoffmann-La Roche
6.2.1 Company Overview
6.2.2 Product And Services Overview
6.2.3 Financial Overview
6.2.4 Key Developments
6.2.5 SWOT Analysis
6.3 Abbott Laboratories
6.3.1 Company Overview
6.3.2 Product And Services Overview
6.3.3 Financial Overview
6.3.4 Key Development
6.3.5 SWOT Analysis
6.4 Biomérieux
6.4.1 Company Overview
6.4.2 Product And Services Overview
6.4.3 Financial Overview
6.4.4 Key Development
6.4.5 SWOT Analysis
6.5 Bio-Rad Laboratories, Inc.
6.5.1 Company Overview
6.5.2 Product And Services Overview
6.5.3 Financial Overview
6.5.4 Key Developments
6.5.5 SWOT Analysis
6.6 Siemens Healthineers (A Subsidiary Of Siemens AG)
6.6.1 Company Overview
6.6.2 Product And Services Overview
6.6.3 Financial Overview
6.6.4 Key Developments
6.6.5 SWOT Analysis
6.7 Ortho Clinical Diagnostics, Inc.
6.7.1 Overview
6.7.2 Product And Services Overview
6.7.3 Financial Overview
6.7.4 Key Developments
6.7.5 SWOT Analysis
6.8 Thermo Fisher Scientific, Inc.
6.8.1 Overview
6.8.2 Product And Services Overview
6.8.3 Financials
6.8.4 Key Developments
6.8.5 SWOT Analysis
6.9 Beckman Coulter (A Subsidiary Of Danaher Corporation)
6.9.1 Overview
6.9.2 Product And Services Overview
6.9.3 Financials
6.9.4 Key Developments
6.9.5 SWOT Analysis
6.10 Becton, Dickinson And Company
6.10.1 Overview
6.10.2 Product And Services Overview
6.10.3 Financials
6.10.4 Key Developments
6.10.5 SWOT Analysis
7 Conclusions and Recommendations
7.1 Global Blood Screening Market Outlook
7.2 Recommendations
8 Glossary
8.1 Associated Visiongain Reports
8.2 Visiongain Report Sales Order Form
8.3 Appendix A
8.4 About Visiongain
8.5 Appendix B
8.6 Visiongain Report Evaluation Form
List of Tables
Table 3.1 PEST Analysis of the Blood Screening Market
Table 3.8 SWOT Analysis of the Blood Screening Market
Table 4.2 Global Blood Screening Reagent and Kits Market 2019-2029
Table 4.2.1 Global Blood Screening NAT Reagents & Kits Market 2019-2029
Table 4.2.2 Global Blood Screening ELISA Reagents & Kits Market 2019-2029
Table 4.3 Global Blood Screening Enzymes and Polymerases Market 2019-2029
Table 4.4 Global Blood Screening Standards And Controls Market 2019-2029
Table 4.5 Global Blood Screening Probes And Primers Market 2019-2029
Table 4.6 Global Blood Screening Buffers, Nucleotides, And Solutions Market 2019-2029
Table 4.7 Global Blood Screening Immunosorbents Market 2019-2029
Table 4.8 Global Blood Screening Controls Market 2019-2029
Table 4.9 Global Blood Screening Instruments Market 2019-2029
Table 4.9.1 Global Blood Screening Rental Purchase Market 2019-2029
Table 4.9.2 Global Blood Screening Outright Purchase Market 2019-2029
Table 4.9.3 Global Blood Screening Software and Services Market 2019-2029
Table 5.2 Canada Blood Screening Market 2019-2029
Table 5.2.1 Canada Blood Screening Submarket, By Type Forecast 2019-2029
Table 5.2.2 Canada Blood Screening Submarket, By Products and Services Forecast 2019-2029
Table 5.2.3 Canada Blood Screening Market Analysis
Table 5.3 U.S. Blood Screening Market 2019-2029
Table 5.3.1 U.S. Blood Screening Submarket, By Type Forecast 2019-2029
Table 5.3.2 U.S. Blood Screening Submarket, By Products and Services Forecast 2019-2029
Table 5.3.3 U.S. Blood Screening Market Analysis
Table 5.4 Germany Blood Screening Market 2019-2029
Table 5.4.1 Germany Blood Screening Submarket, By Type Forecast 2019-2029
Table 5.4.2 Germany Blood Screening Submarket, By Products and Services Forecast 2019-2029
Table 5.4.3 Germany Blood Screening Market Analysis
Table 5.5 France Blood Screening Market 2019-2029
Table 5.5.1 France Blood Screening Submarket, By Type Forecast 2019-2029
Table 5.5.2 France Blood Screening Submarket, By Products and Services Forecast 2019-2029
Table 5.5.3 France Blood Screening Market Analysis
Table 5.6 U.K. Blood Screening Market 2019-2029
Table 5.6.1 U.K. Blood Screening Submarket, By Type Forecast 2019-2029
Table 5.6.2 U.K. Blood Screening Submarket, By Products and Services Forecast 2019-2029
Table 5.6.3 U.K. Blood Screening Market Analysis
Table 5.7 Italy Blood Screening Market 2019-2029
Table 5.7.1 Italy Blood Screening Submarket, By Type Forecast 2019-2029
Table 5.7.2 Italy Blood Screening Submarket, By Products and Services Forecast 2019-2029
Table 5.7.3 Italy Blood Screening Market Analysis
Table 5.8 Spain Blood Screening Market 2019-2029
Table 5.8.1 Spain Blood Screening Submarket, By Type Forecast 2019-2029
Table 5.8.2 Spain Blood Screening Submarket, By Products and Services Forecast 2019-2029
Table 5.8.3 Spain Blood Screening Market Analysis
Table 5.9 China Blood Screening Market 2019-2029
Table 5.9.1 China Blood Screening Submarket, By Type Forecast 2019-2029
Table 5.9.2 China Blood Screening Submarket, By Products and Services Forecast 2019-2029
Table 5.9.3 China Blood Screening Market Analysis
Table 5.10 Australia Blood Screening Market 2019-2029
Table 5.10.1 Australia Blood Screening Submarket, By Type Forecast 2019-2029
Table 5.10.2 Australia Blood Screening Submarket, By Products and Services Forecast 2019-2029
Table 5.10.3 Australia Blood Screening Market Analysis
Table 5.11 India Blood Screening Market 2019-2029
Table 5.11.1 India Blood Screening Submarket, By Type Forecast 2019-2029
Table 5.11.2 India Blood Screening Submarket, By Products and Services Forecast 2019-2029
Table 5.11.3 India Blood Screening Market Analysis
Table 5.12 Indonesia Blood Screening Market 2019-2029
Table 5.12.1 Indonesia Blood Screening Submarket, By Type Forecast 2019-2029
Table 5.12.2 Indonesia Blood Screening Submarket, By Products and Services Forecast 2019-2029
Table 5.13 India Blood Screening Market 2019-2029
Table 5.13.1 India Blood Screening Submarket, By Type Forecast 2019-2029
Table 5.13.2 India Blood Screening Submarket, By Products and Services Forecast 2019-2029
Table 5.13.3 India Blood Screening Market Analysis
Table 5.14 South Korea Blood Screening Market 2019-2029
Table 5.14.1 5.13.1 South Korea Blood Screening Submarket, By Type Forecast 2019-2029
Table 5.14.2 South Korea Blood Screening Submarket, By Products and Services Forecast 2019-2029
Table 5.14.3 South Korea Blood Screening Market Analysis
Table 5.15 Rest of Asia Blood Screening Market 2019-2029
Table 5.15.1 Rest of Asia Blood Screening Submarket, By Type Forecast 2019-2029
Table 5.15.2 Rest of Asia Blood Screening Submarket, By Products and Services Forecast 2019-2029
Table 5.15.3 Rest of Asia Blood Screening Market Analysis
Table 5.16 Middle East Blood Screening Market 2019-2029
Table 5.16.1 Middle East Blood Screening Submarket, By Type Forecast 2019-2029
Table 5.16.2 Middle East Blood Screening Submarket, By Products and Services Forecast 2019-2029
Table 5.16.3 Middle East Blood Screening Market Analysis
Table 5.17 Africa Blood Screening Market 2019-2029
Table 5.17.1 Africa Blood Screening Submarket, By Type Forecast 2019-2029
Table 5.17.2 Africa Blood Screening Submarket, By Products and Services Forecast 2019-2029
Table 5.17.3 Africa Blood Screening Market Analysis
Table 5.18 Rest of the World Blood Screening Market 2019-2029
Table 5.18.1 Rest of the World Blood Screening Submarket, By Type Forecast 2019-2029
Table 5.18.2 Rest of the World Blood Screening Submarket, By Products and Services Forecast 2019-2029
Table 5.18.3 Rest of the World Blood Screening Market Analysis
Table 6.1.3 Grifols Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Table 6.1.5 Grifols Total Company Sales 2014-2019 (US$ bn, AGR %)
Table 6.2.3 F. Hoffmann-La Roche Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Table 6.2.5 F. Hoffmann-La Roche Total Company Sales 2014-2019 (US$ bn, AGR %)
Table 6.3.3 Abbott Laboratories Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Table 6.3.5 Abbott Laboratories Total Company Sales 2014-2019 (US$ bn, AGR %)
Table 6.4.3 Biomérieux Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Table 6.4.5 Biomérieux Total Company Sales 2014-2019 (US$ bn, AGR %)
Table 6.5.3 Bio-Rad Laboratories, Inc. Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Table 6.5.5 Bio-Rad Laboratories, Inc. Total Company Sales 2014-2019 (US$ bn, AGR %)
Table 6.6.3 Siemens Healthineers (A Subsidiary Of Siemens AG) Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Table 6.6.5 Siemens Healthineers (A Subsidiary Of Siemens AG) Total Company Sales 2014-2019 (US$ bn, AGR %)
Table 6.7.3 Ortho Clinical Diagnostics, Inc. Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Table 6.7.5 Ortho Clinical Diagnostics, Inc. Total Company Sales 2014-2019 (US$ bn, AGR %)
Table 6.8.3 Thermo Fisher Scientific, Inc. Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Table 6.8.5 Thermo Fisher Scientific, Inc. Total Company Sales 2014-2019 (US$ bn, AGR %)
Table 6.9.3 Beckman Coulter (A Subsidiary Of Danaher Corporation) Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Table 6.9.5 Beckman Coulter (A Subsidiary Of Danaher Corporation) Total Company Sales 2014-2019 (US$ bn, AGR %)
Table 6.10.3 Becton, Dickinson And Company Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Table 6.10.5 Becton, Dickinson And Company Total Company Sales 2014-2019 (US$ bn, AGR %)
List of Figures
Figure 1.1 Global Blood Screening Market Segmentation
Figure 4.2 Global Blood Screening Reagent and Kits Market 2019-2029
Figure 4.2.1 Global Blood Screening NAT Reagents & Kits Market 2019-2029
Figure 4.2.2 Global Blood Screening ELISA Reagents & Kits Market 2019-2029
Figure 4.3 Global Blood Screening Enzymes and Polymerases Market 2019-2029
Figure 4.4 Global Blood Screening Standards And Controls Market 2019-2029
Figure 4.5 Global Blood Screening Probes And Primers Market 2019-2029
Figure 4.6 Global Blood Screening Buffers, Nucleotides, And Solutions Market 2019-2029
Figure 4.7 Global Blood Screening Immunosorbents Market 2019-2029
Figure 4.8 Global Blood Screening Controls Market 2019-2029
Figure 4.9 Global Blood Screening Instruments Market 2019-2029
Figure 4.9.1 Global Blood Screening Rental Purchase Market 2019-2029
Figure 4.9.2 Global Blood Screening Outright Purchase Market 2019-2029
Figure 4.9.3 Global Blood Screening Software and Services Market 2019-2029
Figure 5.2 Canada Blood Screening Market 2019-2029
Figure 5.2.1 Canada Blood Screening Submarket, By Type Forecast 2019-2029
Figure 5.2.2 Canada Blood Screening Submarket, By Products and Services Forecast 2019-2029
Figure 5.2.3 Canada Blood Screening Market Analysis
Figure 5.3 U.S. Blood Screening Market 2019-2029
Figure 5.3.1 U.S. Blood Screening Submarket, By Type Forecast 2019-2029
Figure 5.3.2 U.S. Blood Screening Submarket, By Products and Services Forecast 2019-2029
Figure 5.3.3 U.S. Blood Screening Market Analysis
Figure 5.4 Germany Blood Screening Market 2019-2029
Figure 5.4.1 Germany Blood Screening Submarket, By Type Forecast 2019-2029
Figure 5.4.2 Germany Blood Screening Submarket, By Products and Services Forecast 2019-2029
Figure 5.4.3 Germany Blood Screening Market Analysis
Figure 5.5 France Blood Screening Market 2019-2029
Figure 5.5.1 France Blood Screening Submarket, By Type Forecast 2019-2029
Figure 5.5.2 France Blood Screening Submarket, By Products and Services Forecast 2019-2029
Figure 5.5.3 France Blood Screening Market Analysis
Figure 5.6 U.K. Blood Screening Market 2019-2029
Figure 5.6.1 U.K. Blood Screening Submarket, By Type Forecast 2019-2029
Figure 5.6.2 U.K. Blood Screening Submarket, By Products and Services Forecast 2019-2029
Figure 5.6.3 U.K. Blood Screening Market Analysis
Figure 5.7 Italy Blood Screening Market 2019-2029
Figure 5.7.1 Italy Blood Screening Submarket, By Type Forecast 2019-2029
Figure 5.7.2 Italy Blood Screening Submarket, By Products and Services Forecast 2019-2029
Figure 5.7.3 Italy Blood Screening Market Analysis
Figure 5.8 Spain Blood Screening Market 2019-2029
Figure 5.8.1 Spain Blood Screening Submarket, By Type Forecast 2019-2029
Figure 5.8.2 Spain Blood Screening Submarket, By Products and Services Forecast 2019-2029
Figure 5.8.3 Spain Blood Screening Market Analysis
Figure 5.9 China Blood Screening Market 2019-2029
Figure 5.9.1 China Blood Screening Submarket, By Type Forecast 2019-2029
Figure 5.9.2 China Blood Screening Submarket, By Products and Services Forecast 2019-2029
Figure 5.9.3 China Blood Screening Market Analysis
Figure 5.10 Australia Blood Screening Market 2019-2029
Figure 5.10.1 Australia Blood Screening Submarket, By Type Forecast 2019-2029
Figure 5.10.2 Australia Blood Screening Submarket, By Products and Services Forecast 2019-2029
Figure 5.10.3 Australia Blood Screening Market Analysis
Figure 5.11 India Blood Screening Market 2019-2029
Figure 5.11.1 India Blood Screening Submarket, By Type Forecast 2019-2029
Figure 5.11.2 India Blood Screening Submarket, By Products and Services Forecast 2019-2029
Figure 5.11.3 India Blood Screening Market Analysis
Figure 5.12 Indonesia Blood Screening Market 2019-2029
Figure 5.12.1 Indonesia Blood Screening Submarket, By Type Forecast 2019-2029
Figure 5.12.2 Indonesia Blood Screening Submarket, By Products and Services Forecast 2019-2029
Figure 5.13 India Blood Screening Market 2019-2029
Figure 5.13.1 India Blood Screening Submarket, By Type Forecast 2019-2029
Figure 5.13.2 India Blood Screening Submarket, By Products and Services Forecast 2019-2029
Figure 5.13.3 India Blood Screening Market Analysis
Figure 5.14 South Korea Blood Screening Market 2019-2029
Figure 5.14.1 5.13.1 South Korea Blood Screening Submarket, By Type Forecast 2019-2029
Figure 5.14.2 South Korea Blood Screening Submarket, By Products and Services Forecast 2019-2029
Figure 5.14.3 South Korea Blood Screening Market Analysis
Figure 5.15 Rest of Asia Blood Screening Market 2019-2029
Figure 5.15.1 Rest of Asia Blood Screening Submarket, By Type Forecast 2019-2029
Figure 5.15.2 Rest of Asia Blood Screening Submarket, By Products and Services Forecast 2019-2029
Figure 5.15.3 Rest of Asia Blood Screening Market Analysis
Figure 5.16 Middle East Blood Screening Market 2019-2029
Figure 5.16.1 Middle East Blood Screening Submarket, By Type Forecast 2019-2029
Figure 5.16.2 Middle East Blood Screening Submarket, By Products and Services Forecast 2019-2029
Figure 5.16.3 Middle East Blood Screening Market Analysis
Figure 5.17 Africa Blood Screening Market 2019-2029
Figure 5.17.1 Africa Blood Screening Submarket, By Type Forecast 2019-2029
Figure 5.17.2 Africa Blood Screening Submarket, By Products and Services Forecast 2019-2029
Figure 5.17.3 Africa Blood Screening Market Analysis
Figure 5.18 Rest of the World Blood Screening Market 2019-2029
Figure 5.18.1 Rest of the World Blood Screening Submarket, By Type Forecast 2019-2029
Figure 5.18.2 Rest of the World Blood Screening Submarket, By Products and Services Forecast 2019-2029
Figure 5.18.3 Rest of the World Blood Screening Market Analysis
Figure 6.1.3 Grifols Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Figure 6.1.5 Grifols Total Company Sales 2014-2019 (US$ bn, AGR %)
Figure 6.2.3 F. Hoffmann-La Roche Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Figure 6.2.5 F. Hoffmann-La Roche Total Company Sales 2014-2019 (US$ bn, AGR %)
Figure 6.3.3 Abbott Laboratories Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Figure 6.3.5 Abbott Laboratories Total Company Sales 2014-2019 (US$ bn, AGR %)
Figure 6.4.3 Biomérieux Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Figure 6.4.5 Biomérieux Total Company Sales 2014-2019 (US$ bn, AGR %)
Figure 6.5.3 Bio-Rad Laboratories, Inc. Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Figure 6.5.5 Bio-Rad Laboratories, Inc. Total Company Sales 2014-2019 (US$ bn, AGR %)
Figure 6.6.3 Siemens Healthineers (A Subsidiary Of Siemens AG) Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Figure 6.6.5 Siemens Healthineers (A Subsidiary Of Siemens AG) Total Company Sales 2014-2019 (US$ bn, AGR %)
Figure 6.7.3 Ortho Clinical Diagnostics, Inc. Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Figure 6.7.5 Ortho Clinical Diagnostics, Inc. Total Company Sales 2014-2019 (US$ bn, AGR %)
Figure 6.8.3 Thermo Fisher Scientific, Inc. Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Figure 6.8.5 Thermo Fisher Scientific, Inc. Total Company Sales 2014-2019 (US$ bn, AGR %)
Figure 6.9.3 Beckman Coulter (A Subsidiary Of Danaher Corporation) Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Figure 6.9.5 Beckman Coulter (A Subsidiary Of Danaher Corporation) Total Company Sales 2014-2019 (US$ bn, AGR %)
Figure 6.10.3 Becton, Dickinson And Company Profile 2019 (Market Entry, Public/Private, Headquarter, Total Company Revenue $bn, Change in Revenue, Geography, Key Market, Listed on, Products/Services, No. of Employees)
Figure 6.10.5 Becton, Dickinson And Company Total Company Sales 2014-2019 (US$ bn, AGR %)
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
